2020-03-05 最新期刊文獻

-
本日Medline新增共35篇期刊文獻。中國學者建議將CT檢查列為早期診斷新冠肺炎依據之一，加拿大學者認為PCR檢驗陰性的患者有類似COVID-19的CT影像異常狀態時，建議隔離治療；但須注意與相關疾病如流感的鑑別診斷重點(22)。CT影像的改變有助於篩檢疑似病例以及監測病情變化(31)。另在藥物研發上，中國學者在實驗室中發現Remdesivir和chloroquine可有效抑制COVID-19病毒(34)。

  1. Anderson PO. (2020). Breastfeeding and Respiratory Antivirals: Coronavirus and Influenza.  Breastfeeding Medicine: The Official Journal of the Academy of Breastfeeding Medicine, doi:10.1089/bfm.2020.29149.poa, https://doi.org/10.1089/bfm.2020.29149.poa 
  2. (2020). Coronavirus response: a focus on containment is still apt.  Nature, 579, 7. doi:10.1038/d41586-020-00623-2, https://doi.org/10.1038/d41586-020-00623-2 
  3. Baruah V & Bose S. (2020). Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.  Journal of Medical Virology, doi:10.1002/jmv.25698, https://doi.org/10.1002/jmv.25698 
  4. Bordi L, Nicastri E, Scorzolini L, Di Caro A, Capobianchi MR, Castilletti C, et al. (2020). Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.8.2000170, https://doi.org/10.2807/1560-7917.ES.2020.25.8.2000170 
  5. Chen L, Liu W, Zhang Q, Xu K, Ye G, Wu W, et al. (2020). RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak.  Emerging Microbes & Infections, 9, 313-319. doi:10.1080/22221751.2020.1725399, https://doi.org/10.1080/22221751.2020.1725399 
  6. Colson P, La Scola B, Esteves-Vieira V, Ninove L, Zandotti C, Jimeno MT, et al. (2020). Letter to the editor: Plenty of coronaviruses but no SARS-CoV-2.  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.8.2000171, https://doi.org/10.2807/1560-7917.ES.2020.25.8.2000171 
  7. COVID-19 National Incident Room Surveillance Team. (2020). COVID-19, Australia: Epidemiology Report 5 (Reporting week ending 19:00 AEDT 29 February 2020).  Communicable Diseases Intelligence, 44, doi:10.33321/cdi.2020.44.20, https://doi.org/10.33321/cdi.2020.44.20 
  8. Cyranoski D. (2020). Mystery deepens over animal source of coronavirus.  Nature, 579, 18-19. doi:10.1038/d41586-020-00548-w, https://doi.org/10.1038/d41586-020-00548-w 
  9. Dai WC, Zhang HW, Yu J, Xu HJ, Chen H, Luo SP, et al. (2020). CT Imaging and Differential Diagnosis of COVID-19.  Canadian Association of Radiologists Journal, 846537120913033. doi:10.1177/0846537120913033, https://doi.org/10.1177/0846537120913033 
  10. Eurosurveillance Editorial Team. (2020). Latest assessment on COVID-19 from the European Centre for Disease Prevention and Control (ECDC).  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.8.2002271, https://doi.org/10.2807/1560-7917.ES.2020.25.8.2002271 
  11. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. (2020). Hematologic parameters in patients with COVID-19 infection.  American Journal of Hematology, doi:10.1002/ajh.25774, https://doi.org/10.1002/ajh.25774 
  12. Gurwitz D. (2020). Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.  Drug Development Research, doi:10.1002/ddr.21656, https://doi.org/10.1002/ddr.21656 
  13. Han Q, Lin Q, Ni Z & You L. (2020). Uncertainties about the transmission routes of 2019 novel coronavirus.  Influenza & Other Respiratory Viruses, doi:10.1111/irv.12735, https://doi.org/10.1111/irv.12735 
  14. Johansson MA & Saderi D. (2020). Open peer-review platform for COVID-19 preprints.  Nature, 579, 29. doi:10.1038/d41586-020-00613-4, https://doi.org/10.1038/d41586-020-00613-4 
  15. Kandeel M, Yamamoto M, Al-Taher A, Watanabe A, Oh-Hashi K, Park BK, et al. (2020). Small Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Fusion by Targeting Cavities on Heptad Repeat Trimers.  Biomolecules & Therapeutics, doi:10.4062/biomolther.2019.202, https://doi.org/10.4062/biomolther.2019.202 
  16. Li G & De Clercq E. (2020). Therapeutic options for the 2019 novel coronavirus (2019-nCoV).  Nature Reviews. Drug Discovery, doi:10.1038/d41573-020-00016-0, https://doi.org/10.1038/d41573-020-00016-0 
  17. Li X, Qian Y, Liu B & Yu Y. (2020). Helping the Radiologist: The Role of Scientific Journals to Help Prevent the Spread of COVID-19.  Radiology, 200661. doi:10.1148/radiol.2020200661, https://doi.org/10.1148/radiol.2020200661 
  18. Mahase E. (2020). Covid-19: UK could delay non-urgent care and call doctors back from leave and retirement.  BMJ, 368, m854. doi:10.1136/bmj.m854, https://doi.org/10.1136/bmj.m854 
  19. Okada P, Buathong R, Phuygun S, Thanadachakul T, Parnmen S, Wongboot W, et al. (2020). Early transmission patterns of coronavirus disease 2019 (COVID-19) in travellers from Wuhan to Thailand, January 2020.  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.8.2000097, https://doi.org/10.2807/1560-7917.ES.2020.25.8.2000097 
  20. Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, et al. (2020). Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.  JAMA, doi:10.1001/jama.2020.3227, https://doi.org/10.1001/jama.2020.3227 
  21. Pan C, Zhang W, Xia JA, Liu H, Du B & Qiu HB. (2020). [Noninvasive Respiratory Support for Novel Coronavirus Pneumonia: Enough is Enough].  Chung-Hua Nei Ko Tsa Chih Chinese Journal of Internal Medicine, 59, E006. doi:10.3760/cma.j.issn.0578-1426.2020.0006, https://doi.org/10.3760/cma.j.issn.0578-1426.2020.0006 
  22. Patlas MN. (2020). COVID-19: What Can We Learn From Stories From the Trenches?.  Canadian Association of Radiologists Journal, 846537120913497. doi:10.1177/0846537120913497, https://doi.org/10.1177/0846537120913497 
  23. Peng X, Xu X, Li Y, Cheng L, Zhou X & Ren B. (2020). Transmission routes of 2019-nCoV and controls in dental practice.  International Journal of Oral Science, 12, 9. doi:10.1038/s41368-020-0075-9, https://doi.org/10.1038/s41368-020-0075-9 
  24. Reusken CB, Haagmans B, Meijer A, Corman VM, Papa A, Charrel R, et al. (2020). Authors' response: Plenty of coronaviruses but no SARS-CoV-2.  Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles = European Communicable Disease Bulletin, 25, doi:10.2807/1560-7917.ES.2020.25.8.2000197, https://doi.org/10.2807/1560-7917.ES.2020.25.8.2000197 
  25. Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, Mendez CA, Zambrano LI, Franco-Paredes C, et al. (2020). COVID-19 in Latin America: The implications of the first confirmed case in Brazil.  Travel Medicine & Infectious Disease, 101613. doi:10.1016/j.tmaid.2020.101613, https://doi.org/10.1016/j.tmaid.2020.101613 
  26. Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, et al. (2020). Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients.  Clinical Infectious Diseases, doi:10.1093/cid/ciaa203, https://doi.org/10.1093/cid/ciaa203 
  27. Tang SY, Xiao YN, Peng ZH & Shen HB. (2020). 新型冠狀病毒肺炎疫情預測建模、數據融合與防控策略分析 [Prediction modeling with data fusion and prevention strategy analysis for the COVID-19 outbreak].  Chung-Hua Liu Hsing Ping Hsueh Tsa Chih Chinese Journal of Epidemiology, 41, 480-484. doi:10.3760/cma.j.cn112338-20200216-00107, https://doi.org/10.3760/cma.j.cn112338-20200216-00107 
  28. Task Force of Pulmonary Function Testing and Clinical Respiratory Physiology, Chinese Association of Chest Physicians & Pulmonary Function Testing Group, Respiratory Therapeutics Group, Chinese Thoracic Society. (2020). 新型冠狀病毒肺炎疫情防控期間開展肺功能檢查的專家共識 [Expert consensus on Pulmonary Function Testing during the epidemic of Corona Virus Disease 2019].  Chung-Hua Chieh Ho Ho Hu Hsi Tsa Chih Chinese Journal of Tuberculosis & Respiratory Diseases, 43, E032. doi:10.3760/cma.j.cn112147-20200225-00175, https://doi.org/10.3760/cma.j.cn112147-20200225-00175 
  29. The Lancet. (2020). COVID-19: fighting panic with information.  Lancet, 395, 537. doi:10.1016/S0140-6736(20)30379-2, https://doi.org/10.1016/S0140-6736(20)30379-2 
  30. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. (2020). Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.  Cell Research, 30, 269-271. doi:10.1038/s41422-020-0282-0, https://doi.org/10.1038/s41422-020-0282-0 
  31. Wang Y, Li X, Liu W, Gan M, Zhang L, Wang J, et al. (2020). Discovery of a subgenotype of human coronavirus NL63 associated with severe lower respiratory tract infection in China, 2018.  Emerging Microbes & Infections, 9, 246-255. doi:10.1080/22221751.2020.1717999, https://doi.org/10.1080/22221751.2020.1717999 
  32. Wertheim JO. (2020). A glimpse into the origins of genetic diversity in SARS-CoV-2.  Clinical Infectious Diseases, doi:10.1093/cid/ciaa213, https://doi.org/10.1093/cid/ciaa213 
  33. Zarocostas J. (2020). What next for the coronavirus response?.  Lancet, 395, 401. doi:10.1016/S0140-6736(20)30292-0, https://doi.org/10.1016/S0140-6736(20)30292-0 
  34. Zhao W, Zhong Z, Xie X, Yu Q & Liu J. (2020). Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study.  AJR. American Journal of Roentgenology, 1-6. doi:10.2214/AJR.20.22976, https://doi.org/10.2214/AJR.20.22976 
  35. Zhu ZW, Tang JJ, Chai XP, Fang ZF, Liu QM, Hu XQ, et al. (2020).疫情流行期間心力衰竭與新型冠狀病毒肺炎患者臨床及影像學特徵的比較 [Comparison of heart failure and 2019 novel coronavirus pneumonia in chest CT features and clinical characteristics].  Chung-Hua Hsin Hsueh Kuan Ping Tsa Chih [Chinese Journal of Cardiology], 48, E007. doi:10.3760/cma.j.cn112148-20200218-00093, https://doi.org/10.3760/cma.j.cn112148-20200218-00093 



留言

張貼留言